Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU.
Francisco Mesonero GismeroYamile ZabanaAgnès Fernández-ClotetEduardo Leo-CarnereroBerta CaballolAndrea Núñez-OrtizMaría José GarcíaFederico BertolettiAlejandro MínguezGerard SurisBegoña CasisRocío Ferreiro-IglesiasMargalida CalafatItxaso JiménezJosé Miranda-BautistaLuis Javier LamuelaIngrid FajardoLeyanira TorrealbaRodrigo NájeraRosa María Sáiz-ChumillasIrene GonzálezMiren VicuñaNatalia García-MoralesAna GutiérrezAlicia López-GarcíaJosé Manuel BenítezCristina Rubín de CélixCoral TejidoEduard BrunetAlejandro Hernández-CambaCristina SuárezIago Rodríguez-LagoMarta PiquerasAndrés CastañoLaura RamosAna SobrinoMaría Carmen Rodríguez-GrauAlfonso ElosuaMiguel MontoroRuth BaltarJosé María HuguetBenito HermidaAntonio Caballero-MateosLuis Sánchez-GuillénAbdel BouhmidiRamón PajaresIria Baston-ReyAntonio López-SanrománAgustin AlbillosManuel Barreiro-de AcostaPublished in: Therapeutic advances in gastroenterology (2024)
Azathioprine may be effective in the long term for the treatment of inflammatory pouch disorders and could be included as a therapeutic option.
Keyphrases